Dacetuzumab

Dacetuzumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from mouse)
TargetCD40
Clinical data
Other namesSGN-40
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
FormulaC6452H9964N1732O1998S42
Molar mass145111.33 g·mol−1
 NY (what is this?)  (verify)

Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies.

This drug was developed by Seattle Genetics, Inc.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.